Zobrazeno 1 - 10
of 21
pro vyhledávání: '"L., VADELOVA"'
Autor:
L., Vadelova1 vadelova2@uniba.sk, M., Skerenova2, J., Ivankova1, A., Vazanova1, J., Sokol1, J., Zolkova1, L., Stanciakova1, I., Skornova1, J., Stasko1
Publikováno v:
Bratislava Medical Journal / Bratislavské Lekárske Listy. 2020, Vol. 121 Issue 10, p700-704. 5p.
Autor:
Jela Ivankova, Juraj Sokol, Jan Stasko, Ingrid Skornova, Lucia Stančiaková, Jana Zolkova, L Vadelova, Maria Skerenova, A Vazanova
Publikováno v:
Bratislava Medical Journal. 121:700-704
Aims We aimed to characterize relationship between the expression profiles of platelet miR-96, miR-126 and miR-223 and platelet function examination in patients with sticky platelet syndrome (SPS) and in healthy controls. Background MicroRNAs (miRNA,
Autor:
Maria Skerenova, A Vazanova, Ingrid Skornova, L Vadelova, Jela Ivankova, Jan Stasko, Jana Zolkova, Juraj Sokol
Publikováno v:
Acta Medica Martiniana. 19:88-94
Introduction: Sticky platelet syndrome (SPS) is referred to as a platelet hyperaggregability triggered by low concentrations of platelet agonists adenosine diphosphate (ADP) and/or epinephrine (EPI). Platelet aggregation with other inducers (collagen
Autor:
Jana Zolkova, Juraj Sokol, Jan Stasko, Dusan Loderer, Ingrid Skornova, Zora Lasabova, L Vadelova, Peter Kubisz, Zuzana Snahnicanova, Tomas Simurda, Miroslava Dobrotova
Publikováno v:
Acta Medica Martiniana, Vol 19, Iss 1, Pp 5-11 (2019)
Genetic testing in patients with von Willebrand disease completes phenotypic testing with an aim to confirm the von Willebrand factor defect at a molecular level. Structure of the VWF gene was described 30 years ago; since then a large number of muta
Autor:
Ingrid Skornova, L Vadelova, Tomáš Bolek, Jela Ivankova, Matej Samoš, Marian Grendar, Jan Stasko, Lucia Stančiaková, Peter Kubisz, Miroslava Dobrotova, Jana Zolkova, Jan Danko, Pavol Holly
Publikováno v:
Diagnostics
Diagnostics, Vol 11, Iss 828, p 828 (2021)
Volume 11
Issue 5
Diagnostics, Vol 11, Iss 828, p 828 (2021)
Volume 11
Issue 5
Thromboprophylaxis with low-molecular-weight heparin (LMWH) for patients with a history of venous thromboembolism (VTE) is suggested. Rotational thromboelastometry (ROTEM®) represents an innovative point-of-care method enabling the complex and quick
Autor:
Jela Ivankova, Jan Stasko, Frantisek Nehaj, Lenka Lisa, Marian Mokan, L Vadelova, Juraj Sokol, M. Mokan, Jana Zolkova
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 26 (2020)
Clinical and Applied Thrombosis/Hemostasis
Clinical and Applied Thrombosis/Hemostasis
Edoxaban, a direct factor Xa inhibitor (FXa), is the fourth direct oral anticoagulant (DOAC) approved for clinical use. As the main adverse event is bleeding, it is relevant whether edoxaban has additional effects on platelet function. We aimed to as
Autor:
Lucia Stančiaková, Jan Stasko, Ingrid Skornova, Matej Samoš, L Vadelova, Frantisek Kovar, Peter Galajda, Peter Kubisz, Tomáš Bolek, M. Mokan, Lukáš Urban, Radoslava Šimonová, Jana Zolkova
Publikováno v:
Acta Medica Martiniana, Vol 18, Iss 2, Pp 34-39 (2018)
Objectives: Several studies have questioned the need for platelet function testing in patients treated with new ADP receptor blockers (ADPRB). The aim of this study was to evaluate the prevalence of high on-treatment platelet reactivity (HTPR) among
Autor:
Jana Zolkova, Juraj Sokol, Egon Kurča, Klaudia Kalmarova, Ingrid Skornova, Jan Stasko, L Vadelova, Vladimir Nosal, J Ballova, Jana Dluha
Publikováno v:
Acta Medica Martiniana, Vol 18, Iss 1, Pp 14-20 (2018)
Aims: The aim of this study was to asses the platelet activation in the acute phase of ischemic stroke and transient ischemic attack (TIA) by defining p-selectin (CD62) expression by flow cytometry in vivo – without stimulation with agonists. We al
Autor:
Jela Ivankova, Jan Stasko, Dusan Loderer, Tomas Simurda, Zora Lasabova, Ingrid Skornova, Peter Kubisz, Juraj Sokol, L Vadelova, Miroslava Dobrotova, Zuzana Snahnicanova, Jana Zolkova
Publikováno v:
Seminars in thrombosis and hemostasis. 46(4)
Sequencing of the gene encoding for von Willebrand factor (VWF) has brought new insight into the physiology of VWF as well as its pathophysiology in the context of von Willebrand disease (VWD). Molecular testing in VWD patients has shown high variabi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.